日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Predicting platinum-resistance in advanced ovarian cancer: defining patient and disease characteristics to improve treatment approaches at initiation of treatment or earlier in the course of the disease

预测晚期卵巢癌的铂类耐药性:明确患者和疾病特征,以在治疗初期或疾病早期改进治疗方案

Chase, Dana M; Patton, Gregory; Annavarapu, Srinivas; Shi, Junxin; Szamreta, Elizabeth; Monberg, Matthew

Navigating complexities of polymorphic microbiomes in endometrial cancer

子宫内膜癌中多态性微生物组的复杂性研究

Jimenez, Nicole R; Herman, Chloe R; Łaniewski, Paweł; Cope, Emily; Lee, Keehoon; Mahnert, Nichole D; Chase, Dana M; Caporaso, J Gregory; Herbst-Kralovetz, Melissa M

Niraparib as First-Line Maintenance Therapy in Patients with Stage III Ovarian Cancer and No Visible Residual Disease: AR1ZE Real-World Study

尼拉帕尼作为一线维持治疗用于III期卵巢癌且无可见残留病灶的患者:AR1ZE真实世界研究

Chase, Dana M; Hanna, Maya; Lim, Jonathan T; Boyle, Tirza Areli Calderón; Guinter, Mark; Richey, Madeline; Patel, Khilna; Schilder, Jeanne M; Hurteau, Jean A; Golembesky, Amanda K

Microbiome impacts quality of life in patients with endometrial cancer and benign gynecological conditions

微生物组影响子宫内膜癌和良性妇科疾病患者的生活质量

Gautam, Nina J; Jimenez, Nicole R; Łaniewski, Paweł; Cui, Haiyan; Roe, Denise J; Chase, Dana M; Herbst-Kralovetz, Melissa M

A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"

“多斯利单抗治疗原发性晚期或复发性子宫内膜癌”的简明语言摘要

Mirza, Mansoor R; Chase, Dana M; Slomovitz, Brian M; Christensen, René dePont; Novák, Zoltán; Black, Destin; Gilbert, Lucy; Sharma, Sudarshan; Valabrega, Giorgio; Landrum, Lisa M; Hanker, Lars C; Stuckey, Ashley; Boere, Ingrid; Gold, Michael A; Auranen, Annika; Pothuri, Bhavana; Cibula, David; McCourt, Carolyn; Raspagliesi, Francesco; Shahin, Mark S; Gill, Sarah E; Monk, Bradley J; Buscema, Joseph; Herzog, Thomas J; Copeland, Larry J; Tian, Min; He, Zangdong; Stevens, Shadi; Zografos, Eleftherios; Coleman, Robert L; Powell, Matthew A

Treatment patterns and outcomes by mismatch repair/microsatellite instability status among patients with primary advanced or recurrent endometrial cancer in the United States

美国原发性晚期或复发性子宫内膜癌患者的治疗模式和结果与错配修复/微卫星不稳定性状态的关系

Chase, Dana M; Kobayashi, Monica; Gomez, Pratyk; Lubinga, Solomon J; Chan, John K

Real-world post-2020 first-line maintenance treatment patterns in patients with advanced ovarian cancer in the US

美国晚期卵巢癌患者2020年后的真实世界一线维持治疗模式

Chase, Dana M; Kalilani, Linda; Cooney, Maureen A; Kiss, Zsofia; Golembesky, Amanda K; Kobayashi, Monica; Dayma, Megha; Coskuncay, Elif; Schilder, Jeanne M

Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263)

一项随机 III 期临床试验的患者报告结果,该试验比较了辅助放疗与放化疗对接受初始根治性子宫切除术和盆腔淋巴结清扫术的中危 I/IIA 期宫颈癌患者的疗效 (NRG/GOG-0263)

Chase, Dana M; Huang, Helen Q; Deng, Wei; Koh, Wui-Jin; Rodgers, William; Small, William Jr; Albuquerque, Kevin; Mayadev, Jyoti; Leath, Charles A; Monk, Bradley; Kim, Beob-Jong; Kim, Dae-Yeon; Cho, Chi Heum; Kim, Jae-Weon; No, Jae Hong; Holman, Laura; Stuckey, Ashley; Fabian, Denise; Smick, Alexandra H; Wenzel, Lari; Gil, Karen; Ryu, Sang Young

Cervicovaginal lavages uncover growth factors as key biomarkers for early diagnosis and prognosis of endometrial cancer

宫颈阴道冲洗液中发现的生长因子可作为子宫内膜癌早期诊断和预后的关键生物标志物

Harris, Hannah J; Łaniewski, Paweł; Cui, Haiyan; Roe, Denise J; Chase, Dana M; Herbst-Kralovetz, Melissa M

Patient Characteristics Associated with Time to Next Treatment in Patients with Ovarian Cancer Treated with Niraparib: The PRED1CT Real-World Study

接受尼拉帕尼治疗的卵巢癌患者下次治疗时间相关的患者特征:PRED1CT 真实世界研究

Chase, Dana M; Shukla, Soham; Moore, Julia; Boyle, Tirza Areli Calderón; Lim, Jonathan; Perhanidis, Jessica; Hurteau, Jean A; Schilder, Jeanne M